Table 2. The relation of CD37 expression and common mutation in AML.
| Total | CD37 low (Z < 1) | CD37 high (Z > 1) | P-value | ||
|---|---|---|---|---|---|
| CD37 low vs. high | Fisher exact test | ||||
| FLT3, number (%) | 0.837 | 1 | |||
| Present | 49 (28.32) | 44 (89.80) | 5 (10.20) | ||
| Absent | 124 (71.67) | 110 (88.71) | 14 (11.29) | ||
| IDH1, number (%) | 0.526 | 1 | |||
| Mutated | 16 (9.25) | 15 (93.75) | 1 (6.25) | ||
| Wild-type | 157 (90.75) | 139 (88.54) | 18 (11.46) | ||
| IDH2, number (%) | 0.914 | 1 | |||
| Mutated | 17 (9.83) | 15 (88.24) | 2 (11.76) | ||
| Wild-type | 156 (90.17) | 139 (89.10) | 17 (10.90) | ||
| RUNX1, number (%) | 0.914 | 1 | |||
| Mutated | 17 (9.83) | 15 (88.24) | 2 (11.76) | ||
| Wild-type | 156 (90.17) | 139 (89.10) | 17 (10.90) | ||
| TET2, number (%) | 0.577 | 1 | |||
| Mutated | 15 (8.67) | 14 (93.33) | 1 (6.67) | ||
| Wild type | 158 (91.33) | 140 (88.61) | 18 (11.39) | ||
| NRAS, number (%) | 0.075 | 0.13 | |||
| Mutated | 12 (6.94) | 9 (75) | 3 (25) | ||
| Wild-type | 161 (93.06) | 145 (90.06) | 16 (9.94) | ||
| CEBPA, number (%) | 0.599 | 0.638 | |||
| Mutated | 13 (7.51) | 11 (84.62) | 2 (15.38) | ||
| Wild-type | 160 (92.49) | 143 (89.38) | 17 (10.63) | ||
| WT1, number (%) | 0.254 | 0.604 | |||
| Mutated | 10 (5.78) | 10 (100) | 0 (0) | ||
| Wild-type | 163 (94.22) | 144 (88.34) | 19 (11.66) | ||
| DNMT3A, number (%) | 0.603 | 0.784 | |||
| Mutated | 45 (26.01) | 41 (91.11) | 4 (8.89) | ||
| Wild-type | 128 (73.99) | 113 (88.28) | 15 (11.72) | ||
| NPM1, number (%) | 0.349 | 0.416 | |||
| Mutated | 48 (27.75) | 41 (85.42) | 7 (14.58) | ||
| Wild-type | 125 (72.25) | 113 (90.4) | 12 (9.6) | ||
| TP53, number (%) | 0.633 | 1 | |||
| Mutated | 14 (8.09) | 13 (92.86) | 1 (7.14) | ||
| Wild-type | 159 (91.91) | 141 (88.68) | 18 (11.32) | ||